Skip to main content
Premium Trial:

Request an Annual Quote

Nanogen to Gain $19M in Stock Placement

NEW YORK, Sept. 28 (GenomeWeb News) - Nanogen expects to raise nearly $20 million through a stock offering to institutional investors scheduled to close today, the company said.

The San Diego-based company will sell 6.8 million shares of its common stock to investors at a price of nearly $3 per share, with 1 million warrants exercisable at $4 per share for five years.

Nanogen anticipates it will reap approximately $18.9 million from the sale and said that it plans to use the net proceeds for working capital, acquisitions and other general corporate purposes.

The Scan

Alzheimer's Risk Gene Among Women

CNN reports that researchers have found that variants in MGMT contribute to Alzheimer's disease risk among women but not men.

Still Hanging Around

The Guardian writes that persistent pockets of SARS-CoV-2 in the body could contribute to long COVID.

Through a Little Spit

Enteric viruses like norovirus may also be transmitted through saliva, not just the fecal-oral route, according to New Scientist.

Nature Papers Present Method to Detect Full Transcriptome, Viruses Infecting Asgard Archaea, More

In Nature this week: VASA-seq approach to detect full transcriptome, analysis of viruses infecting Asgard archaea, and more.